Mullerian Inhibiting Substance inhibits invasion and migration of epithelial cancer cell lines

Henry L. Chang, Rafael Pieretti-Vanmarcke, Fotini Nicolaou, Xianlin Li, Xiaolong Wei, David T. MacLaughlin, Patricia K. Donahoe

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: Given the fact that Mullerian Inhibiting Substance (MIS) causes complex remodeling of the urogenital ridge and regression of the Mullerian ducts during male embryonic development, we examined whether MIS could affect similar cell properties such as migration and invasion that could contribute ultimately to micro-metastasis of cancers arising from Mullerian tissues. MIS receptor expressing cell lines found to be invasive and migratory in vivo are examined in an in vivo assay that is cost-effective. Methods: We designed in vitro and in vivo experiments to determine if MIS inhibited the movement of cancer lines IGROV-1, HEp3, MDA-MB-231, and HT1080 in cell culture invasion/migration chamber assays and in chick embryo metastasis assays. Results: MIS, at concentrations below those that inhibit cell proliferation, blocked in vitro invasion and in vivo migration of epithelial cancer cells that express the MIS receptor. Conclusions: While our laboratory has previously established MIS as an inhibitor of cancer cell proliferation using in vitro assays and in vivo xenografts, we now show that MIS can also inhibit in vivo tumor migration.

Original languageEnglish (US)
Pages (from-to)128-134
Number of pages7
JournalGynecologic oncology
Volume120
Issue number1
DOIs
StatePublished - Jan 2011
Externally publishedYes

Keywords

  • Anti-Mullerian hormone
  • Cell invasion
  • Cell migration
  • Mullerian Inhibiting Substance

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Mullerian Inhibiting Substance inhibits invasion and migration of epithelial cancer cell lines'. Together they form a unique fingerprint.

Cite this